U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07007416) titled 'Impact of Supraphysiological Estradiol on ECG in IVF Patients' on May 28.
Brief Summary: This prospective observational study aimed to evaluate the effects of supraphysiological estradiol (E2) levels, induced by gonadotropin therapy during IVF, on cardiac electrophysiological parameters. Sixty-two women aged 18-40 undergoing IVF treatment at Konya City Hospital between December 2024 and January 2025 were included.
ECG recordings were performed twice: once before gonadotropin stimulation and again on the day of hCG administration, when peak E2 levels were expected. Routine blood tests and hormone levels were also evaluated. Patients ...